New York, NY -- (SBWIRE) -- 01/22/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: New Residential Investment Corp (NYSE:NRZ), Newcastle Investment Corp (NYSE:NCT), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Silver Standard Resources Inc. (USA) (NASDAQ:SSRI)
New Residential Investment Corp (NYSE:NRZ) showed a volume of 2.55 million shares by the end of last trade whereas the average volume of the stock remained 1.79 million shares. The stock opened the session at $6.48 but then moved to $6.46. At that price, the stock showed a positive performance of 0.78%. New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate.
Will NRZ Continue To Move Higher? Find Out Here
Newcastle Investment Corp (NYSE:NCT) opened the session at $5.87 and closed the session at $5.86. The stock showed a positive performance of 0.51% in previous trading session. Traded with volume of 2.55 million shares in the prior session and the average volume of the stock remained 3.70 million shares. Newcastle Investment Corp. (Newcastle) is a real estate investment and finance company. Newcastle invests in, and actively manages, a portfolio of, real estate securities, loans, excess mortgage servicing rights (MSRs) and other real estate related assets.
For How Long NCT will fight for Profitability? Read This Trend Analysis report
Inovio Pharmaceuticals Inc (NYSEMKT:INO) opened the session at $2.63 and closed the session at $2.50. The stock showed a negative performance of -2.34% in previous trading session. Traded with volume of 2.55 million shares in the prior session and the average volume of the stock remained 5.56 million shares. The beta of the stock remained 3.26. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens,
Why Should Investors Buy INO After the Recent Fall? Just Go Here and Find Out
Silver Standard Resources Inc. (USA) (NASDAQ:SSRI) the stock advanced 2.21% and finished the session at $8.34. Traded with volume of 2.61 million shares in the prior session and the average volume of the stock remained 1.93 million shares. The beta of the stock remained 1.26. Silver Standard Resources Inc. is a silver resource company. The Company’s properties are located in six countries in the Americas. The Company is focused on operating and producing silver from the Pirquitas Mine, which is located in the Province of Jujuy,
Will SSRI Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)